Medical Watch Disease & Treatment News

Dr. Jennifer Reynolds' update at the BC Lupus Society symposium highlights that lupus research moves slowly, with limited new trial details emerging...

• Targets 'undruggable' KRAS: Drug binds cyclophilin A to shut down mutated protein driving 90%+ of tumors.
• Survival boost: Overall survival rose...

The FDA approved Shionogi's Xocova as the first oral post-exposure Covid-19 prevention for adults and adolescents 12+, cutting symptomatic infection...

• Yale's STEP platform, funded by a $40M NIH grant, claims compact 10nm Cas9 RNPs can reach deep brain regions via intrathecal routes, potentially...

Biohub's AI model, trained on 2.8 billion protein sequences, designed entirely new proteins that were validated in laboratory tests, including a...

Alzheimer's R&D is rapidly expanding past amyloid, with diverse mechanisms now dominating a record pipeline.

• Anti-amyloid share dropped to 16% from...

The Norman and Mary Pattiz Foundation's $3 million gift to USC Keck School of Medicine establishes the Norman and Mary Pattiz Alzheimer’s Research...

Two strategies are tackling traditional CAR-T limits like manufacturing complexity and solid tumor challenges.

• AI-optimized design: Waypoint Bio's...

Business agreements and regulatory moves are converging to ease CGT commercialization barriers.

• Cencora-Kite partnership handles order management,...

Sintilimab plus chemoradiotherapy extended progression-free survival in locally advanced small cell lung cancer, delivering the first major advance in decades. Manageable side effects position this phase II approach for potential standard care.

The Allen Institute has launched the Brain Health Accelerator, a global initiative backed by $400 million to accelerate mechanistic understanding and...

Regulatory support and industry strategy are aligning to scale gene therapies into larger patient populations.

• FDA's new draft guidance encourages...

A simple blood test may help detect and stage Alzheimer's disease, potentially transforming early diagnosis and ongoing monitoring.

Pancreatic Cancer Advances

• 🔥 daraxonrasib Phase 3 Results: In a Phase 3 randomized trial published in the New England Journal of Medicine,...

Cell therapies navigate overlapping FDA rules from drug GMPs, tissue standards, and biologics requirements, creating compliance complexity.

• Core...

Red light and near-infrared therapy offers a promising non-pharmacological approach to boost brain function and protect against cognitive decline. Dr....

The Alzheimer's field has shifted from one-target failures to a multi-mechanism pipeline with two approved DMTs and unprecedented trial volume.

• 192...

Monell researcher Bruce Kimball identifies chemical biomarkers in urine samples from young athletes that match those found in animal models of brain injury, paving the way for non-invasive concussion tests and recovery tracking.

Fourteen-year-old Creed Kolasa lives with Duchenne Muscular Dystrophy, a condition affecting 1 in 3,500-5,000 boys that weakens muscles due to missing...

AI systems now detect Alzheimer's via MRI brain scans years before symptoms emerge.

• Trio of models cleans images, targets gray matter, and votes for...